Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Comorbidity Burden in Elderly Persons with Non-CML Myeloproliferative Neoplasms: Real-World Evidence From a United States Medicare Population

Keith L Davis, MA, Gregory L Price, MPH, Sudeep Karve, PhD, Gerhardt M Pohl, PhD, Richard A Walgren, MD, PhD

Blood (2012) 120 (21): 1734.

https://doi.org/10.1182/blood.V120.21.1734.1734

Published: 2012

Journal Articles

Health Care Utilization and Associated Costs in Elderly Persons with Non-CML Myeloproliferative Neoplasms: Real-World Evidence From a United States Medicare Population

Sudeep Karve, PhD, Gregory L Price, MPH, Keith L Davis, MA, Gerhardt M Pohl, PhD, Richard A Walgren, MD, PhD

Blood (2012) 120 (21): 4273.

https://doi.org/10.1182/blood.V120.21.4273.4273

Published: 2012

Journal Articles

Survival Patterns in Patients with Non-CML Myeloproliferative Neoplasms: Evidence From a United States SEER/Medicare Population

Gregory L. Price, MPH, Keith L Davis, MA, Sudeep Karve, PhD, Gerhardt M Pohl, PhD, Richard A Walgren, MD, PhD

Blood (2012) 120 (21): 428.

https://doi.org/10.1182/blood.V120.21.428.428

Published: 2012

Journal Articles

A Retrospective Observational Comparison of Comorbidities Between Myeloproliferative Neoplasm (MPN) Patients and Matched Controls in a Commercially Insured US Population

Gregory L Price, MPH, Gerhardt M Pohl, PhD, Jin Xie, MS, Richard A Walgren, MD, PhD

Blood (2011) 118 (21): 3140.

https://doi.org/10.1182/blood.V118.21.3140.3140

Published: 2011

Journal Articles

A Retrospective Observational Study of Annual Healthcare Costs for Patients with Forms of Myeloproliferative Neoplasms (MPN)

Gregory L Price, MPH, Gerhardt M Pohl, PhD, Jin Xie, MS, Richard A Walgren, MD, PhD

Blood (2011) 118 (21): 2060.

https://doi.org/10.1182/blood.V118.21.2060.2060

Published: 2011

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Comorbidity Burden in Elderly Persons with Non-CML Myeloproliferative Neoplasms: Real-World Evidence From a United States Medicare Population

Health Care Utilization and Associated Costs in Elderly Persons with Non-CML Myeloproliferative Neoplasms: Real-World Evidence From a United States Medicare Population

Survival Patterns in Patients with Non-CML Myeloproliferative Neoplasms: Evidence From a United States SEER/Medicare Population

A Retrospective Observational Comparison of Comorbidities Between Myeloproliferative Neoplasm (MPN) Patients and Matched Controls in a Commercially Insured US Population

A Retrospective Observational Study of Annual Healthcare Costs for Patients with Forms of Myeloproliferative Neoplasms (MPN)

Email alerts

ASH Publications

American Society of Hematology

Update search

Comorbidity Burden in Elderly Persons with Non-CML Myeloproliferative Neoplasms: Real-World Evidence From a United States Medicare Population

Health Care Utilization and Associated Costs in Elderly Persons with Non-CML Myeloproliferative Neoplasms: Real-World Evidence From a United States Medicare Population

Survival Patterns in Patients with Non-CML Myeloproliferative Neoplasms: Evidence From a United States SEER/Medicare Population

A Retrospective Observational Comparison of Comorbidities Between Myeloproliferative Neoplasm (MPN) Patients and Matched Controls in a Commercially Insured US Population

A Retrospective Observational Study of Annual Healthcare Costs for Patients with Forms of Myeloproliferative Neoplasms (MPN)

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only